These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12665422)

  • 1. The therapeutic potential of costimulatory blockade with CTLA4Ig in rheumatoid arthritis.
    Emery P
    Expert Opin Investig Drugs; 2003 Apr; 12(4):673-81. PubMed ID: 12665422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.
    Kremer JM; Westhovens R; Leon M; Di Giorgio E; Alten R; Steinfeld S; Russell A; Dougados M; Emery P; Nuamah IF; Williams GR; Becker JC; Hagerty DT; Moreland LW
    N Engl J Med; 2003 Nov; 349(20):1907-15. PubMed ID: 14614165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis.
    Teng GG; Turkiewicz AM; Moreland LW
    Expert Opin Biol Ther; 2005 Sep; 5(9):1245-54. PubMed ID: 16120053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting costimulatory activation of T cells : a viable treatment option for rheumatoid arthritis?
    Pollard LC
    Drugs; 2007; 67(1):1-9. PubMed ID: 17209660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Abatacept].
    Nakamura T; Matsubara T
    Nihon Rinsho; 2013 Jul; 71(7):1232-7. PubMed ID: 23961672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective costimulation modulators: a novel approach for the treatment of rheumatoid arthritis.
    Kremer JM
    J Clin Rheumatol; 2005 Jun; 11(3 Suppl):S55-62. PubMed ID: 16357751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-stimulatory blockade as therapy for rheumatoid arthritis.
    Mackie SL; Vital EM; Ponchel F; Emery P
    Curr Rheumatol Rep; 2005 Oct; 7(5):400-6. PubMed ID: 16174492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting lymphocyte activation to treat rheumatoid arthritis.
    Falgarone G; Semerano L; Rullé S; Boissier MC
    Joint Bone Spine; 2009 Jul; 76(4):327-32. PubMed ID: 19535279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of CTLA4-Ig on radiographic outcome of patients with rheumatoid arthritis].
    Harigai M
    Clin Calcium; 2007 Apr; 17(4):577-84. PubMed ID: 17404488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
    Sherrer Y
    Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CTLA4-Ig (abatacept)].
    Harigai M
    Nihon Rinsho; 2007 Jul; 65(7):1231-7. PubMed ID: 17642237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA4Ig: a novel inhibitor of costimulation.
    Dall'Era M; Davis J
    Lupus; 2004; 13(5):372-6. PubMed ID: 15230295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of abatacept in rheumatoid arthritis: a review.
    Khraishi M; Russell A; Olszynski WP
    Clin Ther; 2010 Oct; 32(11):1855-70. PubMed ID: 21095481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA4Ig and the therapeutic potential of T cell co-stimulation blockade.
    Graca L
    Acta Reumatol Port; 2008; 33(3):267-76. PubMed ID: 18846007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immunogenicity of the T cell costimulation modulator abatacept in patients treated for rheumatoid arthritis.
    Haggerty HG; Abbott MA; Reilly TP; DeVona DA; Gleason CR; Tay L; Dodge R; Aranda R
    J Rheumatol; 2007 Dec; 34(12):2365-73. PubMed ID: 18050376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abatacept in the treatment of active rheumatoid arthritis].
    Nielsen H; Hansen A
    Ugeskr Laeger; 2009 Jan; 171(4):214-7. PubMed ID: 19174034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abatacept, a novel CD80/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis.
    Korhonen R; Moilanen E
    Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):276-84. PubMed ID: 19228144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abatacept.
    Vital EM; Emery P
    Drugs Today (Barc); 2006 Feb; 42(2):87-93. PubMed ID: 16541185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation.
    Konsta M; Rallis E; Karameris A; Stratigos A; Sfikakis PP; Iliopoulos A
    J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):257-8. PubMed ID: 22280512
    [No Abstract]   [Full Text] [Related]  

  • 20. T-cell agents in the treatment of rheumatoid arthritis.
    Solomon GE
    Bull NYU Hosp Jt Dis; 2010; 68(3):162-5. PubMed ID: 20969545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.